Latham & Watkins represented the underwriters in the transaction. Immunovant, Inc. executed its underwritten public offering of 5,270,093 shares of its common stock at a price…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now